Giampaolo Ugolini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Giampaolo Ugolini has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Isacco Montroni
Colorectal Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
5 shared publications - Mario Taffurelli
Breast Unit, Department of Woman and Child, IRCCS Azienda Ospedaliero-Universitaria of Bologna, 40138 Bologna, Italy
3 shared publications - Donatella Santini
Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy
2 shared publications Giancarlo Rosati
Department of Medical and Surgical Sciences, University of Bologna, Policlinico S.Orsola-Malpighi, Italy
2 shared publications- Simone Zanotti
Breast Unit, Department of Woman, Child and Urological Diseases, Sant'Orsola Hospital, University of Bologna, Bologna, Italy
2 shared publications - Aldo Roda
Department of Chemistry “G. Ciamician”, University of Bologna, 40126 Bologna, Italy
1 shared publication
Latest Publications
- 31 March 2010
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 123 (3) , 895-900
Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision
Nipple discharge (ND) is a common symptom seen in breast cancer clinics. The primary aim of this study was to identify preoperative risk factors for breast cancer in patients with pathologic ND. The secondary aim was to assess the clinical and pathological effectiveness of physical examination, galactography, cytological examination of the discharge, selective duct excision and ductoscopy. All patients operated on between 1975 and 2008 who presented with ND as their only symptom was analyzed. Discharge’s characteristics, cytological data and galactography reports were recorded. The relationship between each individual finding and the risk of breast cancer was calculated. For each diagnostic tool, the sensitivity, specificity and complication rates were calculated and compared. Nine-hundred-fifteen patients underwent selective duct excision. Two-hundred-nineteen patients (23.9%) were found to be affected by carcinoma. In 100/330 (30.3%) patients with bloody discharge and in 42/239 (17.6%) patients with serous secretion cancer was detected (P = 0.004, P = 0.013, respectively). Patients with sero-sanguinous or coloured discharge had the same risk of cancer as the population analyzed (23.9%, P = NS). Galactographic finding of irregular stenosis seemed to be associated with a higher risk of cancer (P = 0.0001). Cytological findings C5 and C4 were associated with cancer (P = 0.001). Selective duct excision showed highest sensitivity and specificity. In conclusion, the well established role of bloody secretion is confirmed. The supposed benign aetiology of serous, coloured or sero-sanguinous discharge is questionable. The high specificity of the cytological exam justifies routine examination of the ND. Selective duct excision can be considered as the diagnostic gold-standard.
- 31 March 2010
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 123 (3) , 895-900
Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision
Nipple discharge (ND) is a common symptom seen in breast cancer clinics. The primary aim of this study was to identify preoperative risk factors for breast cancer in patients with pathologic ND. The secondary aim was to assess the clinical and pathological effectiveness of physical examination, galactography, cytological examination of the discharge, selective duct excision and ductoscopy. All patients operated on between 1975 and 2008 who presented with ND as their only symptom was analyzed. Discharge’s characteristics, cytological data and galactography reports were recorded. The relationship between each individual finding and the risk of breast cancer was calculated. For each diagnostic tool, the sensitivity, specificity and complication rates were calculated and compared. Nine-hundred-fifteen patients underwent selective duct excision. Two-hundred-nineteen patients (23.9%) were found to be affected by carcinoma. In 100/330 (30.3%) patients with bloody discharge and in 42/239 (17.6%) patients with serous secretion cancer was detected (P = 0.004, P = 0.013, respectively). Patients with sero-sanguinous or coloured discharge had the same risk of cancer as the population analyzed (23.9%, P = NS). Galactographic finding of irregular stenosis seemed to be associated with a higher risk of cancer (P = 0.0001). Cytological findings C5 and C4 were associated with cancer (P = 0.001). Selective duct excision showed highest sensitivity and specificity. In conclusion, the well established role of bloody secretion is confirmed. The supposed benign aetiology of serous, coloured or sero-sanguinous discharge is questionable. The high specificity of the cytological exam justifies routine examination of the ND. Selective duct excision can be considered as the diagnostic gold-standard.
- Open Access
- 8 August 2008
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 227
Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines
EGFR is frequently overexpressed in colon cancer. We characterized HT-29 and Caco-2, human colon cancer cell lines, untreated and treated with cetuximab or gefitinib alone and in combination with EGF.
- 8 August 2008
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 227
Open AccessDisplayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines
EGFR is frequently overexpressed in colon cancer. We characterized HT-29 and Caco-2, human colon cancer cell lines, untreated and treated with cetuximab or gefitinib alone and in combination with EGF.
- 30 April 2008
- Published by Elsevier in Gastroenterology
- Vol. 134 (4)
W1287 A Novel Magnetic Device to Prevent Fecal Incontinence
- 30 April 2008
- Published by Elsevier in Gastroenterology
- Vol. 134 (4)
W1287 A Novel Magnetic Device to Prevent Fecal Incontinence
- 30 April 2008
- Published by Elsevier in Gastroenterology
- Vol. 134 (4)
M1691 IFN-γ and Lamina Propria Lymphocytes (LPLS) Regulate Sox9 and Gp180 Expression in Fresh Intestinal Epithelial Cells (IECs)
- 30 April 2008
- Published by Elsevier in Gastroenterology
- Vol. 134 (4)
M1691 IFN-γ and Lamina Propria Lymphocytes (LPLS) Regulate Sox9 and Gp180 Expression in Fresh Intestinal Epithelial Cells (IECs)